gdc-0980
Showing 1 - 10 of 10
Non-Hodgkin's Lymphoma, Solid Cancers Trial in Boston, Villejuif, Manchester (GDC-0980)
Completed
- Non-Hodgkin's Lymphoma, Solid Cancers
- GDC-0980
-
Boston, Massachusetts
- +2 more
Nov 1, 2016
Solid Cancers Trial in Spain, United States (GDC-0980, bevacizumab, capecitabine)
Completed
- Solid Cancers
- GDC-0980
- +3 more
-
Los Angeles, California
- +3 more
Nov 1, 2016
Breast Cancer Trial in Boston, Nashville, Leuven (GDC-0980, bevacizumab, paclitaxel)
Completed
- Breast Cancer
- GDC-0980
- +2 more
-
Boston, Massachusetts
- +2 more
Nov 1, 2016
Non-Hodgkin's Lymphoma, Solid Cancers Trial in United Kingdom, United States (GDC-0980)
Completed
- Non-Hodgkin's Lymphoma, Solid Cancers
- GDC-0980
-
Chicago, Illinois
- +4 more
Nov 1, 2016
Solid Cancers Trial in Spain, United States (GDC-0980, bevacizumab, carboplatin)
Completed
- Solid Cancers
- GDC-0980
- +5 more
-
Los Angeles, California
- +4 more
Nov 1, 2016
Endometrial Carcinoma Trial in United States (GDC-0980)
Completed
- Endometrial Carcinoma
- GDC-0980
-
Phoenix, Arizona
- +27 more
Aug 9, 2016